On July 21, Science published an article detailing possible misconduct in some influential 2006 US research on the potential cause of Alzheimer’s disease. These reports have raised questions about the overall nature of funding research on the causes of Alzheimer's disease.
Research and patient services need to reflect that Canadians from diverse communities are living with dementia
Recent data from Statistics Canada on our country’s demographic shift to an aging population highlights Canada’s evolving future. How we respond to these changes will determine our long-term success as a nation, especially for future generations of older individuals.
In the report, Egale Canada and National Institute on Ageing researchers ask: What are the unique experiences and needs of two-spirit, lesbian, gay, bisexual, transgender, queer, and intersex (2SLGBTQI) people living with dementia and those who care for them?
The Alzheimer Society of Canada has been made aware of the decision by Biogen Canada Inc. to withdraw its submission of aducanumab from regulatory review by Health Canada as a treatment for people living with early stages of Alzheimer’s disease.
It is with profound sadness and a truly heavy heart that we share the news that dementia researcher and advocate Dr. Karen Kobayashi passed away on May 28, 2022.
Jeff Carney, former President and CEO of IG Wealth Management, was diagnosed with early onset Alzheimer’s in 2020. As a long-time and passionate advocate for people living with Alzheimer’s, Jeff continues to raise awareness and support for those impacted by dementia.